Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial - Judson, I; Verweij, J; Gelderblom, H (Lancet Oncol, 2014)